Fundz

Biobot Surgical secured $18M in a Series B funding led by Tony Tan for its Mona Lisa surgical robot.

PRIVATEMar 07, 2024

Amount Raised

$18 Million

Round Type

Series B

SingaporeManufacturingBiotechnologyHealth CareMedicalMedical Device

Investors

Zig VenturesTony Tan

Description

Biobot Surgical closed a Series B funding round worth $18 million. The round was led by healthcare entrepreneur Tony Tan and saw participation from existing shareholder Zig Ventures. The funds will be used to accelerate the company's global expansion and commercial footprint.

Quick answer

Biobot Surgical raised $18 Million in a Series B round, dated March 7, 2024. Investors: Zig Ventures and Tony Tan. Biobot Surgical is based in Singapore, Southeast Asia, Singapore.

How much did Biobot Surgical raise?
Biobot Surgical raised $18 Million in a Series B round on March 7, 2024.
Who invested in Biobot Surgical?
Zig Ventures and Tony Tan are named as investors in this round.
What does Biobot Surgical do?
BIOBOT is a medical technology company dedicated to redefining the standard of care in urology through technological innovation.
Where is Biobot Surgical based and how big is it?
Biobot Surgical is based in Singapore, Southeast Asia, Singapore.
Who are the decision-makers at Biobot Surgical?
Fundz holds 2 contacts at Biobot Surgical, including the President. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Biobot Surgical that raised within 45 days of this round, from Fundz verified event records.

  • Neurovalens raised $2.7M (Seed) on April 8, 2024.
  • Tenon Medical raised $2.6M (Seed) on February 20, 2024.
  • Procyrion raised $58M (Series E) on February 5, 2024.
  • icotec ag raised $30M (Funding Round) on January 25, 2024.
  • icotec ag raised $30M (Funding Round) on January 24, 2024.
  • OsseoLabs raised $2M (Series A) on April 15, 2024.

Who to call at Biobot Surgical, and when

A new round usually means Biobot Surgical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Biobot Surgical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Biobot Surgical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Biobot Surgical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Biobot Surgical

Location

Singapore, Southeast Asia, Singapore

About

BIOBOT is a medical technology company dedicated to redefining the standard of care in urology through technological innovation. Its flagship product, the iSR'obot Mona Lisa system, arms urologists with cutting-edge robotic precision and enhanced visualization for percutaneous transperineal procedures.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Biobot Surgical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsAdrian W., President hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Biobot Surgical's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Biobot Surgical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.